Powder Delivery TRIZ Cases

Segmented nanoparticle probes resolve the contradiction between binding strength and penetration depth by combining slip bonds with high affinity moieties.

Hydrolysed block copolymers form stable macromolecular assemblies with lipids to solubilize hydrophobic active agents in aqueous solutions.

Bariatricus massiliensis selectively inhibits Class I HDACs, addressing off-target effects from broad-spectrum inhibitors.

Adjusting the teverelix-trifluoroacetate molar ratio to 1:2.0 prevents gel formation and eliminates specialized equipment needs.

Medium chain fatty acids in the formula improve nutrient absorption to address gastrointestinal conditions and motor-planning speech difficulties.

Titanium oxide and silver composite particles inactivate allergens through photocatalysis, avoiding side effects from chemical agents.

Messenger RNA vaccines encode Chikungunya, Zika, and Dengue antigens to induce balanced immunity without insertional mutagenesis risks.

Hydrogel co-monomers inhibit micelle formation to extend the dynamic range of fatty acid detection without sample dilution.

Replacing monoclonal antibodies with short peptides reduces immunogenicity while maintaining tumor targeting and penetration.

Grinding moist cellulose derivatives in a gas-swept impact mill increases onset dissolution temperature, preventing gel-blocking during cold water processing.

Replacing low-efficiency scFv vectors with high-affinity DARPins improves transduction specificity for CAR T cell generation.

Merges micronized palmitoylethanolamide and cytidine-diphosphocholine to reduce neuroinflammation and oxidative stress, protecting against cerebral damage.

Cryoprotectants and chelators mitigate phase separation in lipid nanoparticle formulations, maintaining encapsulation efficiency for nucleic acid delivery.

Administering TGF-beta antagonists during the perinatal period to inhibit pathological signaling and promote normal lung development in premature infants.

Water-in-oil emulsion with crosslinked polysaccharide hydrogel particles delivers biologically active agents via diffusion and controlled degradation.

A telomerase-derived peptide composition targets benign prostatic hyperplasia by inhibiting 5α-reductase expression and cell proliferation.

Antibody-conjugated polymeric vehicles deliver drugs specifically to the uterus, minimizing systemic cardiovascular side effects from off-target exposure.

Nanoparticle carriers deliver conserved flavivirus peptides to induce cross-protective immunity against multiple viral strains without adverse reactions.

Formula I compounds activate melanocortin-3 receptors while blocking melanocortin-4 receptors.

PEI-modified tumor-derived microparticles enhance antigen presentation and reduce synthesis time.

Pneumatic atomization produces sub-micron particles without thermal stress, preserving biological activity.

Ionizing radiation generates Cherenkov light to activate nuclear photosensitizers, reducing required doses and sparing normal tissue.

Porous inorganic oxide particles adsorb liquid drugs to improve bioavailability while maintaining flowability for high-dose processing.

Covalent ATRA-polyvinyl alcohol conjugation via hydrolyzable linkers enables sustained dermal release, reducing irritation from rapid bolus absorption.

Hydrophobic NRTI prodrugs conjugated with alkyl groups improve biodistribution to resolve adherence issues from complex dosing schedules.

Cross-linked polymeric nanoparticles solubilize poorly water-soluble drugs via a hydrophobic core and hydrophilic shell structure.

Pre-mixed buffering agents and stabilizers in a single vial enable high radiochemical purity during rapid 68Ga chelation without multi-step handling.

A kaolin dispersed aqueous composition promotes blood clotting through surface adsorption while maintaining low viscosity for surgical application.

A polydextrose polymer matrix promotes rapid disintegration of water-insoluble active principles in aqueous media.

Eccentric vibrating mills grind zinc oxide to micron sizes, boosting solubility and bioavailability.

Small molecule inhibitors replace antibodies to resolve low specificity and high costs while enabling efficient detection of disease-related targets.

Spark discharge generates metal nanoparticles for gas-phase aerosol coating, eliminating liquid chemical waste while enabling controlled drug release rates.

Helical fluidized bed spray drying stabilizes exenatide with a saccharide coating, preventing protein denaturation during low-temperature processing.

Pancreatin pellets form exclusively from pancreatin using heat-induced plasticity for extrusion and spheronization.

LION nanoparticles deliver RNA via cationic lipids while iron oxide cores enable MRI tracking to resolve stability and detection trade-offs.

Amphiphilic copolymer-coated iron oxide nanoparticles enable selective accumulation in tumor cells via surface ligand binding.

Phosphor carriers convert X-rays into visible light to activate photoactivatable drugs, enabling precise tumor targeting while minimizing side effects.

Biodegradable microspheres encapsulate secretome agents to mimic stem cell paracrine effects without immunological risks.

Salts and cocrystals of a mutant IDH inhibitor address enzyme specificity challenges while maintaining treatment effectiveness.

Antioxidant addition maintains polyamide yellow index stability across multiple heating cycles.

pH-responsive polymeric nanoparticles resolve particle instability and cytotoxicity by switching charge states to enable controlled intracellular siRNA release.

Superparamagnetic iron oxide nanoparticles transport therapeutic agents across biological barriers using external magnetic fields.

Dissolving active ingredients in a solid solvent and pressurizing with supercritical fluid gas to form nanoscale particles.

Thermokinetic processing forms an inclusion complex between a cyclic oligomer and an active pharmaceutical ingredient, resolving poor aqueous solubility.

Submicron protein spheres redistribute along blood vessel walls to protect vital organs, reducing mortality without complex manufacturing.

Local inhalation of factor inhibitors prevents clot formation and fibrosis while avoiding systemic side effects.